Browsing: Life Insurance Capital Solutions
Longevity and Mortality Investor’s coverage of life insurance company reinsurance and alternative risk transfer activity
Despite property representing a major source of household wealth, equity release is largely still absent from retirement planning discussions in the UK, according to new research from Canada Life.
Melville-Kelly now reports to Jim Boyd, CEO, and remains director of risk and compliance; the restructure follows a December Extraordinary General Meeting (EGM) where members agreed to a special resolution broadening the Council’s remit across all forms of later life lending within the regulated mortgage environment.
Well over half (58%) of defined benefit pension scheme members in the UK would support their scheme running on to generate a surplus, according to the latest Excellence in Endgames research paper from Hymans Robertson.
The Dr. Martens Airwair Group Pension Plan has completed a £37.5m bulk purchase annuity buy-in with Pension Insurance Corporation. The deal covers the 455 plan members.
Well over half (58%) of defined benefit pension scheme members in the UK would support their scheme running on to generate a surplus, according to the latest Excellence in Endgames research paper from Hymans Robertson.
New PRA discussion paper provides insight into the UK regulator’s thinking on potential reforms to the existing ISPV regime.
A convergence of themes has contributed to the growth story of the US life and annuity market of the past few years.
Total US annuity sales increased 4% to $119.3bn in the third quarter of 2025, setting yet another quarterly sales record, according to LIMRA. This marks the eighth consecutive quarter of $100+bn in sales.
The subject of whether life insurance-linked securities (life ILS) structures should be rated or not is a conversation almost as old as the market itself.
Longevity and Mortality Investor (LMI) is the new name for Life Risk News. Greg Winterton caught up with Chris Wells, Managing Editor at LMI, to discuss the reasons behind the rebrand, his thoughts on how the longevity and mortality markets have evolved in recent years, and plans for the future.